Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GRK3 Antisense RNA 1 (GRK3-AS1)
- Target
- GRK3-AS1
- Molecular classification
- Antisense RNA, Long noncoding RNA (lncRNA), Noncoding RNA, Other (not a typical receptor/enzyme/transporter)
01
Overview
GRK3 Antisense RNA 1 (GRK3-AS1) is a long noncoding antisense RNA gene transcribed from the GRK3 locus. As an antisense transcript, it is complementary to GRK3 mRNA and may regulate GRK3 gene expression through epigenetic, transcriptional, or post-transcriptional mechanisms. Antisense RNAs select for chromatin modification, transcriptional interference, and potential splicing regulation. While antisense RNAs are broadly implicated in regulating cellular processes and disease pathways, there are no direct links or documented protein-coding functions, nor is GRK3-AS1 reported as a direct drug target to date.
- Other names
- CTA-407F11.8GRK3-AS1
02
Mechanism of action
Not applicable. However, generic antisense oligonucleotide (ASO) drugs can mediate RNA degradation against antisense RNAs by RNase H or influence splicing in other contexts
03
Biological functions
Regulation of gene expression (via antisense mechanisms)Epigenetic regulationTranscriptional interferencePotential involvement in alternative splicingPossible role in chromatin remodeling
04
Disease associations
Other (no direct disease association reported for GRK3-AS1 specifically)General: Antisense RNAs and lncRNAs are implicated in cancer and genomic imprinting, but no specific disease role for GRK3-AS1 itself is reported
Beyond the preview
Go deeper on GRK3 Antisense RNA 1 (GRK3-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GRK3 Antisense RNA 1 (GRK3-AS1).